{
    "nct_id": "NCT03204123",
    "official_title": "PSMA PET Imaging of Recurrent Prostate Cancer",
    "inclusion_criteria": "* Biopsy proven adenocarcinoma of the prostate\n* Initially treated with definitive local therapy (surgery and radiation therapy are the most common treatments, but other treatments are also eligible)\n* For patients initially treated with surgery, radiation therapy, brachytherapy, or cryotherapy:\n\n  * PSA ≥ 0.2 ng/mL in at least two consecutive tests within 6 months of date of consent for patients\n  * Note: The most recent PSA value must be within 6 weeks of consent\n* For patients who have received additional treatment in the recurrent or metastatic setting:\n\n  ° PSA ≥ 2 ng/ml above the most recent therapy nadir\n* Age ≥ 18 years\n* Patient must be able to tolerate PET/CT or PET/MR imaging\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patient with claustrophobia that would preclude PET/CT or PET/MR imaging or other contraindications to CT imaging.",
    "miscellaneous_criteria": ""
}